Home

Akoya BioSciences, Inc. - Common Stock (AKYA)

3.0200
+0.0300 (1.00%)

Akoya Biosciences Inc is a biotechnology company that specializes in advanced spatial biology solutions

It focuses on developing innovative tools and technologies that enable researchers to study the complex interactions within biological tissues at a high level of detail. By providing cutting-edge platforms for multiplexed imaging and analysis, Akoya empowers scientists in various fields, including cancer research and immunology, to gain deeper insights into cellular environments and disease mechanisms. Their mission is to enhance the understanding of biology and improve the development of therapies through precision, high-throughput spatial analysis.

SummaryNewsPress ReleasesChartHistoricalFAQ
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 21, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 10, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 15, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 9, 2024
A Closer Look at 4 Analyst Recommendations For Akoya Biosciencesbenzinga.com
Via Benzinga · August 6, 2024
Analyst Scoreboard: 4 Ratings For Akoya Biosciencesbenzinga.com
Via Benzinga · June 3, 2024
Recap: Akoya Biosciences Q4 Earningsbenzinga.com
Via Benzinga · March 4, 2024
Earnings Outlook For Akoya Biosciencesbenzinga.com
Via Benzinga · March 1, 2024
Earnings Scheduled For November 14, 2024benzinga.com
Via Benzinga · November 14, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · October 7, 2024
AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024investorplace.com
AKYA stock results show that Akoya Biosciences met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 14, 2024
Analyst Ratings for Akoya Biosciencesbenzinga.com
Via Benzinga · December 14, 2023
Expert Ratings for Akoya Biosciencesbenzinga.com
Via Benzinga · November 13, 2023
Recap: Akoya Biosciences Q3 Earningsbenzinga.com
Via Benzinga · November 8, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · May 14, 2024
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 14, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 14, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!
Via InvestorPlace · May 14, 2024
Where Akoya Biosciences Stands With Analystsbenzinga.com
Via Benzinga · October 16, 2023
AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024investorplace.com
AKYA stock results show that Akoya Biosciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · May 13, 2024
AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023investorplace.com
AKYA stock results show that Akoya Biosciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 4, 2024
Earnings Scheduled For March 4, 2024benzinga.com
Companies Reporting Before The Bell • Sohu.com (NASDAQSOHU) is estimated to report earnings for its fourth quarter.
Via Benzinga · March 4, 2024
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'benzinga.com
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQTRIP) is not good enough, and he prefers Booking Holdings Inc. NASDAQ: BKNGNASDAQBKNG)
Via Benzinga · July 20, 2023